Eclipse Therapeutics, Inc.

Eclipse Therapeutics is a private biotech firm committed to discovering and developing innovative cancer treatments, with a focus on targeting cancer stem cells. These cells are believed to play a crucial role in tumor growth, spread, and recurrence, and are also associated with resistance to standard cancer therapies. By utilizing their extensive knowledge of cancer stem cell biology and therapeutic antibodies, Eclipse aims to create novel treatments that address unmet needs in cancer patient care. The company's headquarters are located in San Diego, CA and was established in 2011 by former Biogen Idec employees Peter Chu, Christopher Reyes, and Jonathan Lim.